가축 건강 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 치료제별, 진단약별, 지역별＆경쟁(2021-2031년)

The global cattle health market is projected to expand significantly, rising from USD 10.19 billion in 2025 to USD 16.84 billion by 2031, demonstrating an 8.73% compound annual growth rate. This market includes a variety of pharmaceutical treatments, biological vaccines, and specialized medicinal feed additives designed to diagnose, prevent, and manage diseases in bovine animals. Key factors driving this growth include the increasing worldwide demand for beef and dairy proteins, which requires effective herd management to boost output and reduce fatalities.

Furthermore, stringent regulatory requirements concerning food safety and the prevention of zoonotic disease transmission are enforcing rigorous veterinary health protocols throughout agricultural supply chains to meet international trade standards. Despite this robust demand, a major obstacle to market expansion is the increasing expense and intricacy of gaining regulatory approval for new veterinary therapeutics, which can hinder innovation and delay product introductions. This demanding landscape necessitates companies navigating extensive compliance processes, even as the enormous size of the livestock sector, exemplified by the 86.7 million cattle in the U.S. in 2025, highlights the crucial and ongoing need for these veterinary products and health interventions.

Market Driver

The primary driver of the cattle health market is the escalating global demand for high-quality beef and dairy products, which drives producers to optimize herd productivity. This imperative leads to the widespread use of pharmaceutical treatments and nutritional supplements, ensuring livestock efficiently achieve desired weight and lactation targets. The financial impact is visible in the industry, as demonstrated by Zoetis's livestock portfolio achieving 11% operational revenue growth in the third quarter of 2024. Moreover, the extensive scale of international trade necessitates stringent health maintenance to meet export standards, with global beef exports projected at approximately 12.9 million tons in 2025, underscoring the vast livestock population requiring continuous veterinary attention.

A crucial secondary driver is the increasing occurrence of infectious and zoonotic bovine diseases, which compels all stakeholders to prioritize biosecurity and preventive care. Recent outbreaks, such as H5N1 in dairy herds, have spurred the rapid implementation of diagnostics and urgent health interventions to avert supply chain disruptions. In response to these threats, substantial public funding is being allocated for disease mitigation to safeguard the agricultural economy, evidenced by the USDA's allocation of $824 million in May 2024 for rapid response and testing. This elevated disease prevalence directly boosts demand for vaccines and advanced biosecurity technologies, thereby reinforcing the sector's resilience against evolving biological risks.

Market Challenge

The global cattle health market's expansion is considerably hampered by the rising costs and intricate nature of regulatory approval for new veterinary therapeutics. Adhering to these stringent compliance mandates across various jurisdictions requires manufacturers to commit significant financial resources and extensive time to ensure safety and efficacy. This substantial investment of capital consequently curtails companies' capacity to invest in the research and development of groundbreaking treatments, thereby slowing the introduction of vital advanced biologicals and medicinal feed additives necessary for effective herd management.

As a direct result, the market suffers from a lack of product diversity, which limits the available options for addressing new bovine diseases. The protracted timelines necessary for compliance testing not only delay revenue generation but also deter prospective market entrants. The Animal Health Institute noted that in 2025, the average development period for a new veterinary pharmaceutical remained at 8.5 years due to these rigorous mandatory review processes. This extended cycle directly impedes the industry's ability to swiftly address immediate livestock health requirements and constrains its overall growth potential.

Market Trends

The widespread adoption of Precision Livestock Farming (PLF) Technologies is fundamentally transforming the cattle health market, shifting herd management from reactive observation to proactive, data-driven decision-making in real-time. Farmers are increasingly utilizing wearable sensors and smart ear tags to monitor vital signs, rumination patterns, and behavioral changes, enabling early detection of illness before overt clinical symptoms manifest. This technological evolution facilitates individualized animal care at an industrial scale, significantly enhancing labor efficiency and improving treatment outcomes, as evidenced by Merck Animal Health's SenseHub Dairy Technology monitoring over 2 million dairy cows in the United States by August 2025.

Simultaneously, a growing emphasis on preventive biologics and immunotherapy is guiding the industry towards mitigating emerging infectious threats and reducing reliance on antibiotics. Stakeholders are prioritizing the creation of innovative vaccines to safeguard herds against high-impact transboundary diseases, thereby accelerating the commercial availability of advanced immunological solutions. This concentrated effort on biosecurity innovation is bolstered by substantial public investments aimed at securing the food supply chain from viral outbreaks, with the USDA allocating up to $100 million in March 2025 to fund projects including the development of novel vaccines for highly pathogenic avian influenza in livestock.

Key Market Players

• Qiagen LLC
• Boehringer Ingelheim International GmbH
• Thermo Fisher Scientific Inc.
• Elanco Animal Health Inc.
• Idexx Laboratories Inc.
• Kyoritsuseiyaku Corporation
• Merck & Co Inc.
• Norbrook laboratories Ltd.
• Zeotis Inc

Report Scope

In this report, the Global Cattle Health Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cattle Health Market, By Therapeutics

• Vaccine
• Parasiticide
• Anti-infective
• Medical Feed Additive
• Other Therapeutics

Cattle Health Market, By Diagnostics

• Immunodiagnostic Test
• Molecular Diagnostics
• Diagnostic Imaging
• Clinical Chemistry
• Other Diagnostics

Cattle Health Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cattle Health Market.

Available Customizations:

Global Cattle Health Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cattle Health Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Therapeutics (Vaccine, Parasiticide, Anti-infective, Medical Feed Additive, Other Therapeutics)
  • 5.2.2. By Diagnostics (Immunodiagnostic Test, Molecular Diagnostics, Diagnostic Imaging, Clinical Chemistry, Other Diagnostics)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Cattle Health Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Therapeutics
  • 6.2.2. By Diagnostics
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cattle Health Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Therapeutics
      • 6.3.1.2.2. By Diagnostics
  • 6.3.2. Canada Cattle Health Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Therapeutics
      • 6.3.2.2.2. By Diagnostics
  • 6.3.3. Mexico Cattle Health Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Therapeutics
      • 6.3.3.2.2. By Diagnostics

7. Europe Cattle Health Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Therapeutics
  • 7.2.2. By Diagnostics
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Cattle Health Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Therapeutics
      • 7.3.1.2.2. By Diagnostics
  • 7.3.2. France Cattle Health Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Therapeutics
      • 7.3.2.2.2. By Diagnostics
  • 7.3.3. United Kingdom Cattle Health Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Therapeutics
      • 7.3.3.2.2. By Diagnostics
  • 7.3.4. Italy Cattle Health Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Therapeutics
      • 7.3.4.2.2. By Diagnostics
  • 7.3.5. Spain Cattle Health Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Therapeutics
      • 7.3.5.2.2. By Diagnostics

8. Asia Pacific Cattle Health Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Therapeutics
  • 8.2.2. By Diagnostics
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Cattle Health Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Therapeutics
      • 8.3.1.2.2. By Diagnostics
  • 8.3.2. India Cattle Health Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Therapeutics
      • 8.3.2.2.2. By Diagnostics
  • 8.3.3. Japan Cattle Health Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Therapeutics
      • 8.3.3.2.2. By Diagnostics
  • 8.3.4. South Korea Cattle Health Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Therapeutics
      • 8.3.4.2.2. By Diagnostics
  • 8.3.5. Australia Cattle Health Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Therapeutics
      • 8.3.5.2.2. By Diagnostics

9. Middle East & Africa Cattle Health Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Therapeutics
  • 9.2.2. By Diagnostics
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Cattle Health Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Therapeutics
      • 9.3.1.2.2. By Diagnostics
  • 9.3.2. UAE Cattle Health Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Therapeutics
      • 9.3.2.2.2. By Diagnostics
  • 9.3.3. South Africa Cattle Health Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Therapeutics
      • 9.3.3.2.2. By Diagnostics

10. South America Cattle Health Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Therapeutics
  • 10.2.2. By Diagnostics
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Cattle Health Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Therapeutics
      • 10.3.1.2.2. By Diagnostics
  • 10.3.2. Colombia Cattle Health Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Therapeutics
      • 10.3.2.2.2. By Diagnostics
  • 10.3.3. Argentina Cattle Health Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Therapeutics
      • 10.3.3.2.2. By Diagnostics

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Cattle Health Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Qiagen LLC
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Boehringer Ingelheim International GmbH
• 15.3. Thermo Fisher Scientific Inc.
• 15.4. Elanco Animal Health Inc.
• 15.5. Idexx Laboratories Inc.
• 15.6. Kyoritsuseiyaku Corporation
• 15.7. Merck & Co Inc.
• 15.8. Norbrook laboratories Ltd.
• 15.9. Zeotis Inc

16. Strategic Recommendations

17. About Us & Disclaimer